Page breadcrumb nav

VAERS Report 2157008

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Male

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2021-10-18
Date d’apparition
125
Nombre de jours (date d’apparition – date de vaccination)
125
Description de l’événement indésirable

drug ineffective; tested +ve for covid on lft following 3 previous doses of comirnaty; this is a spontaneous report received from a contactable reporter(s) (pharmacist). the reporter is the patient. a 42 year-old male patient received bnt162b2 (comirnaty), administration date 18oct2021 (batch/lot number: unknown) as dose 3 (booster), single, administration date 23mar2021 (batch/lot number: unknown) as dose 2, single and administration date 05jan2021 (batch/lot number: unknown) as dose 1, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. the following information was reported: drug ineffective (medically significant) with onset 20feb2022, outcome "recovering", described as "drug ineffective"; covid-19 (medically significant) with onset 20feb2022, outcome "recovering", described as "tested +ve for covid on lft following 3 previous doses of comirnaty". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (20feb2022) positive, notes: nasal swab. therapeutic measures were not taken as a result of covid-19. clinical information: patient did not received any other vaccines within 4 weeks prior to the covid vaccine. patient did not received any other medications the patient received within 2 weeks of vaccination. no covid-19 was diagnosed prior to vaccination. since the vaccination patient been tested for covid-19. the lot number for bnt162b2 was not provided and will be requested during follow up.; sender's comments: based on available information a contributory role of bnt162b2 to the reported events covid-19 and drug ineffective cannot be totally excluded as efficacy of a drug varies from individual to individual depending upon the immune status. as with any vaccine, vaccination with bnt162b2 may not protect all vaccine recipients, so the expectedness of covid-19 and drug ineffective is : expected. the case will be reassessed further upon receipt of additional information.,linked report(s) : gb-pfizer inc-202200328211 same patient and product/ different dose and event

Données de laboratoire
test date: 20220220; test name: lateral flow; test result: positive ; comments: nasal swab
Liste des symptômes
drug ineffective covid-19 sars-cov-2 test
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na